Sue Ashton
- General Health Professions top 5%
- Molecular Biology
- Issues, ethics and legal aspects top 1%
- Oncology
- Cancer Research
- Co-authors
- Hugh McKennaSinead KeeneyAnderson J. RyanF. Russell WestwoodDavid C. BlakeyMike WalkerPeter D. DavisGareth Hughes
- Topics
- Angiogenesis and VEGF in Cancer (5 papers)Cancer, Hypoxia, and Metabolism (3 papers)Primary Care and Health Outcomes (2 papers)
- Partner nations
- United KingdomFranceNetherlands
In The Last Decade
Sue Ashton
11 papers receiving 507 citations
Peers
Comparison fields: 5 of 87
- General Health Professions 201
- Molecular Biology 183
- Issues, ethics and legal aspects 97
- Oncology 95
- Cancer Research 95
Countries citing papers authored by Sue Ashton
This map shows the geographic impact of Sue Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Ashton more than expected).
Fields of papers citing papers by Sue Ashton
This network shows the impact of papers produced by Sue Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Ashton. The network helps show where Sue Ashton may publish in the future.
Co-authorship network of co-authors of Sue Ashton
This figure shows the co-authorship network connecting the top 25 collaborators of Sue Ashton. A scholar is included among the top collaborators of Sue Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Ashton. Sue Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 72 | |
| 5 | 44 | |
| 6 | 24 | |
| 7 | 9 | |
| 8 | 156 | |
| 9 | 73 | |
| 10 | Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. | 147 |
| 11 | ZD6126, a novel vascular targeting agent, induces rapid changes to tumor blood vessel endothelial cells in an Hras5 nude mouse xenograft model. | 1 |
About Sue Ashton
Sue Ashton is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 11 papers that have together received 540 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Primary Care and Health Outcomes (2 papers). The work is most often cited by research in Issues, ethics and legal aspects (97 citations), General Health Professions (201 citations) and Research and Theory (6 citations). Sue Ashton has collaborated with scholars based in United Kingdom, France and Netherlands. Frequent co-authors include Hugh McKenna, Sinead Keeney, Anderson J. Ryan, F. Russell Westwood, David C. Blakey, Mike Walker, Peter D. Davis, Gareth Hughes, Laurent Hennequin and Sian Taylor. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer and Journal of Advanced Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.